Background: Blood conservation is a major concern in the management of surgical patients because of transfusion- related complications, limited supply, and health care costs. Tranexamic acid (TXA) and ε aminocaproic acid (ε ACA) are lysine analogue antifibrinolytics used to reduce surgical bleeding and transfusions.